Study of Eye Movement Testing and Therapy

Oculomotor Dysfunction Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00472485
• Other study ID #: 00H0185
• Status: Completed
• Phase: N/A
• First received: May 9, 2007
• Last updated: July 1, 2008

Study information

• Verified date: July 2008
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 8 Years to 13 Years

Eligibility

Inclusion Criteria:

• Children ages 8 to 13 with saccadic eye movement deficit

Exclusion Criteria:

• Previous saccadic eye movement therapy

Study Design

Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Oculomotor Deficiency
• Oculomotor Dysfunction
• Saccadic Eye Movement Deficiency

Intervention

Procedure:
• eye movement therapy

Locations

Country	Name	City	State
United States	The Ohio State University	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Ohio State University

Country where clinical trial is conducted

United States,